Back to Search
Start Over
Foundation Medicine Announces Global Collaboration With Lilly to Develop FoundationOne(r)CDx and FoundationOne(r)Liquid CDx as Companion Diagnostics for RETEVMO(r) and Loxo Oncology
- Source :
- Plus Company Updates. February 10, 2022
- Publication Year :
- 2022
-
Abstract
- CAMBRIDGE, Mass.: Foundation Medicine, Inc. announced a collaboration with Eli Lilly and Company (Lilly) for the development of Foundation Medicine's tissue- and blood-based assays as companion diagnostics for RETEVMO(r) and [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Plus Company Updates
- Publication Type :
- News
- Accession number :
- edsgcl.693740250